Monoclonal antibodies to gastrin hormone

Details for Australian Patent Application No. 2005228897 (hide)

Owner Cancer Advances, Inc.

Inventors Grimes, Stephen; Makishima, Ronald

Agent Spruson & Ferguson

Pub. Number AU-B-2005228897

PCT Pub. Number WO2005/095459

Priority 10/813,336 29.03.04 US; 60/557,759 29.03.04 US

Filing date 29 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 10 December 2009

International Classifications

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095459 Priority application(s): WO2005/095459

29 January 2009 Assignment before Grant

  Receptor BioLogix, Inc. The application has been assigned to Cancer Advances, Inc.

10 December 2009 Application Accepted

  Published as AU-B-2005228897

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228899-Substituted thiophene derivatives as anti-cancer agents

2005228894-Macrocyclic compounds as inhibitors of viral replication